Cannabis in Palliative Medicine: Improving Care and Reducing Opioid-Related Morbidity

被引：39
|
作者：
Carter, Gregory T. [1 ]
Flanagan, Aaron M.
Earleywine, Mitchell [2 ]
Abrams, Donald I. [3 ]
Aggarwal, Sunil K. [4 ]
Grinspoon, Lester [5 ,6 ]
机构：
[1] Providence Med Grp, Hospice Serv, Olympia, WA USA
[2] SUNY Albany, Dept Psychol, Albany, NY 12222 USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] NYU, Rusk Inst Rehabil Med, New York, NY 10003 USA
[5] Harvard Univ, Sch Med, Dept Psychiat, Cambridge, MA 02138 USA
[6] Massachusetts Mental Hlth Ctr, Boston, MA 02115 USA
来源：
AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE | 2011年 / 28卷 / 05期
关键词：
cannabis; medical marijuana; opioids; hospice; chronic pain; palliative medicine; CHRONIC NEUROPATHIC PAIN; UNITED-STATES; COMPARATIVE SAFETY; WASHINGTON-STATE; OVERDOSE DEATHS; CB1; RECEPTORS; SPINAL-CORD; MARIJUANA; ALCOHOL; TRENDS;
D O I：
10.1177/1049909111402318
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
Unlike hospice, long-term drug safety is an important issue in palliative medicine. Opioids may produce significant morbidity. Cannabis is a safer alternative with broad applicability for palliative care. Yet the Drug Enforcement Agency (DEA) classifies cannabis as Schedule I (dangerous, without medical uses). Dronabinol, a Schedule III prescription drug, is 100% tetrahydrocannabinol (THC), the most psychoactive ingredient in cannabis. Cannabis contains 20% THC or less but has other therapeutic cannabinoids, all working together to produce therapeutic effects. As palliative medicine grows, so does the need to reclassify cannabis. This article provides an evidence-based overview and comparison of cannabis and opioids. Using this foundation, an argument is made for reclassifying cannabis in the context of improving palliative care and reducing opioid-related morbidity.
引用
收藏
页码：297 / 303
页数：7
相关论文
共 32 条
  • [1] Opioid-related compartment syndrome and associated morbidity
    Rao, Sandesh S.
    Mawn, J. Gregory
    Lobaton, Gilberto O.
    Puvanesarajah, Varun
    Amin, Raj M.
    Humbyrd, Casey Jo
    Sterling, Robert S.
    INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2019, 50 (08): : 1429 - 1432
  • [2] Recreational Cannabis Legalization and Opioid-Related Deaths in Colorado, 2000-2015
    Livingston, Melvin D.
    Barnett, Tracey E.
    Delcher, Chris
    Wagenaar, Alexander C.
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2017, 107 (11) : 1827 - 1829
  • [3] Impact of Recreational Cannabis Legalization on Opioid Prescribing and Opioid-Related Hospital Visits in Colorado: an Observational Study
    Christine Buttorff
    George Sam Wang
    Asa Wilks
    Gregory Tung
    Amii Kress
    Dan Schwam
    Rosalie Liccardo Pacula
    Journal of General Internal Medicine, 2023, 38 : 2726 - 2733
  • [4] Impact of Recreational Cannabis Legalization on Opioid Prescribing and Opioid-Related Hospital Visits in Colorado: an Observational Study
    Buttorff, Christine
    Wang, George Sam
    Wilks, Asa
    Tung, Gregory
    Kress, Amii
    Schwam, Dan
    Pacula, Rosalie Liccardo
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 (12) : 2726 - 2733
  • [5] A Health System-Wide Initiative to Decrease Opioid-Related Morbidity and Mortality
    Weiner, Scott G.
    Price, Christin N.
    Atalay, Ale J.
    Harry, Elizabeth M.
    Pabo, Erika A.
    Patel, Rajesh
    Suzuki, Joji
    Anderson, Shelly
    Ashley, Stanley W.
    Kachalia, Allen
    JOINT COMMISSION JOURNAL ON QUALITY AND PATIENT SAFETY, 2019, 45 (01) : 3 - 13
  • [6] Examining the association of rurality with opioid-related morbidity and mortality in Georgia: A geospatial analysis
    Roth, Kimberly B.
    Goplerud, Dana K.
    Babjak, Jennifer S.
    Nguyen, Jennifer L.
    Gilbert, Lauren R.
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2024, 162
  • [7] The State of the Evidence on the Association Between State Cannabis Laws and Opioid-Related Outcomes: a Review
    Tormohlen, Kayla N.
    Bicket, Mark C.
    White, Sarah
    Barry, Colleen L.
    Stuart, Elizabeth A.
    Rutkow, Lainie
    McGinty, Emma E.
    CURRENT ADDICTION REPORTS, 2021, 8 (04) : 538 - 545
  • [8] Potential public health impacts of medical cannabis availability on opioid-related harms? Urgent but un-answered questions from Canada
    Fischer, Benedikt
    Jones, Wayne
    Hall, Wayne
    Kurdyak, Paul
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2019, 73 : 96 - 99
  • [9] Effects of Opioid-Related Policies on Opioid Utilization, Nature of Medical Care, and Duration of Disability
    Neumark, David
    Savych, Bogdan
    AMERICAN JOURNAL OF HEALTH ECONOMICS, 2023, 9 (03) : 331 - 373
  • [10] Recreational cannabis laws and opioid-related emergency department visit rates
    Drake, Coleman
    Wen, Jiebing
    Hinde, Jesse
    Wen, Hefei
    HEALTH ECONOMICS, 2021, 30 (10) : 2595 - 2605
1234